Skip to main content

Year: 2019

AgraFlora Organics To Acquire 88-Acre Outdoor Cannabis Grow and 27,000 Sq. Ft. Licensed Cannabis Processing Facility

VANCOUVER, British Columbia, Dec. 05, 2019 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc.  (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased to announce the Company has entered into an interim agreement (the “Agreement”) to acquire 100 per-cent of the issued and outstanding shares of Sanna Health Corp. (“Sanna”). Sanna is a Canadian cannabis company based in the Greater Toronto Area (the “GTA”), which boasts the following licenses awarded under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”):Standard Cultivation License;Standard Processing License; and,Medical Sales License.Brandon Boddy, Chairman and Chief Executive Officer of AgraFlora stated: “This is a landmark acquisition for AgraFlora, a transaction...

Continue reading

Mandatory Notice of Trade in IDEX Biometrics – Incentive Subscription Rights 4 December 2019

On 4 December 2019, VP of Finance Erling Svela was granted incentive subscription rights (SRs) under the IDEX Biometrics’s 2019 incentive subscription rights plan. The exercise price of the SRs is NOK 0.15 per share. 50% of the SRs vest per year over two years and the SRs expire on 9 May 2024. After the grant, Mr. Svela holds 203,167 shares and 618,100 SRs in IDEX.

Continue reading

 Olainfarm Group announced the appointment of a new executive

Today, the Supervisory Council of JSC Olainfarm approved Elena Bushberg as a member of the Management Board and CEO of Olainfarm, a part of Olainfarm Group of companies. Elena Bushberg brings over 25 years of international pharmaceutical experience to the Management Board in areas such as finance, supply & operations, marketing and sales in CIS countries, with engagement in creating, managing, and leading high performing teams and developing talent across multiple business areas.In order for the company to achieve its future strategic goals, JSC Olainfarm Supervisory Council has improved the distribution of corporate governance functions: 1) the Chairman of the Management Board of JSC Olainfarm monitors the corporate governance of the Olainfarm Group of companies; 2) a member of the Olainfarm Management Board acts as the CEO of the...

Continue reading

“Olainfarm” grupa ieceļ jaunu valdes locekli un izpilddirektori

Šodien AS “Olainfarm” padome apstiprināja Elenu Bušbergu (Elena Bushberg) valdes locekli un izpilddirektori. Viņai ir vairāk nekā 25 gadu pieredze starptautiskos farmācijas uzņēmumos tādās jomās kā finanses, piegāde, mārketings un pārdošana NVS valstīs, kā arī rezultatīvu komandu izveidē un vadībā, attīstot ekspertīzi dažādās biznesa jomās.Lai uzņēmums sasniegtu savus nākamos stratēģiskos mērķus, AS “Olainfarm” padome ir pilnveidojusi uzņēmuma pārvaldības funkciju sadali: 1) “Olainfarm” valdes priekšsēdētājs veic arī “Olainfarm” grupas uzņēmumu pārvaldības uzraudzību; 2) viens no “Olainfarm” valdes locekļiem ir atbildīgs par izpilddirektora funkcijām grupas lielākajam uzņēmumam “Olainfarm”.Pagājušajā nedēļā par AS “Olainfarm” valdes priekšsēdētāju apstiprināja Jerūnu Veitesu (Jeroen Weites), kuram uzticēta visu uzņēmumu grupas kopējā...

Continue reading

Grant of Incentive Subscription Rights in IDEX 4 Dec 2019

The board of directors of IDEX Biometrics ASA resolved on 4 December 2019 to issue 4,938,543 incentive subscription rights to employees in the IDEX group. The grant was made under the company’s 2019 incentive subscription rights plan as resolved at the annual general meeting on 9 May 2019. The exercise price of the subscription rights is NOK 0.15 per share. The subscription rights vest by 50% per year over two years and expire on 9 May 2024. Following the grant there will be 54,911,643 subscription rights outstanding in IDEX.For further information contact:Derek P. D’Antilio, CPAChief Financial OfficerTel: +1 978 273 1344derek.dantilio@idexbiometrics.comErling SvelaVP FinanceTel: +47 4062 1040erling.svela@idexbiometrics.comAbout IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of fingerprint...

Continue reading

Nano Dimension Appoints New President & CEO

Seasoned Turnaround Executive Yoav Stern Takes the Helm as Nano Dimension’s Incoming President & CEO Succeeding Co-Founder Amit Dror who is Taking the Role of Customer Success OfficerNESS ZIONA, Israel, Dec. 05, 2019 (GLOBE NEWSWIRE) —  Nano Dimension Ltd., a leading additive electronics’ manufacturing provider (NASDAQ, TASE: NNDM), announced today the appointment of veteran turnaround executive, Yoav Stern as President and Chief Executive Officer, effective January 2, 2020. He will be succeeding the co-founder and current CEO Amit Dror, who is taking the executive role of Customer Success Officer reporting directly to Mr. Stern. Mr. Dror will also continue to serve as a director on the company’s Board of Directors.  Mr. Stern is a seasoned executive with a proven track record spanning decades in operating roles as CEO and...

Continue reading

Ramirent appoints Erik Bengtsson as Chief Executive Officer and Jukka Havia as Deputy Chief Executive Officer

Ramirent Plc              Stock Exchange Release      December 5, 2019 at 09:30 EETRamirent Plc’s Board of Directors has appointed Erik Bengtsson as Chief Executive Officer, CEO, of Ramirent Plc effective January 1, 2020. Erik Bengtsson has since September 1, 2018 held the position Executive Vice President of Sweden, Group Fleet and Sourcing. Erik Bengtsson has a strong track record in the equipment rental industry, having previously been member of the Ramirent Board of Directors from March 2017 to August 2018, and having held various senior managerial roles in the industry since 2005. Erik Bengtsson will also become a member of the Loxam Group’s Executive Committee.Until the appointment of a successor, Erik Bengtsson will continue in his current position in parallel to his new role.Jukka Havia has been appointed Deputy CEO of Ramirent...

Continue reading

Ramirent nimittää Erik Bengtssonin konsernin toimitusjohtajaksi ja Jukka Havian varatoimitusjohtajaksi

Ramirent Oyj              Pörssitiedote               5.12.2019 klo 9.30Ramirent Oyj:n hallitus on nimittänyt Erik Bengtssonin Ramirent Oyj:n toimitusjohtajaksi 1. tammikuuta 2020 alkaen. Erik Bengtsson on toiminut 1. syyskuuta 2018 alkaen Ramirentin Ruotsin toiminnoista sekä konsernin kalustosta ja hankinnoista vastaavana johtajana. Erik Bengtssonilla on vahva tausta konevuokrausalalla. Ennen nykyistä tehtäväänsä hän oli Ramirentin hallituksen jäsen maaliskuusta 2017 elokuuhun 2018 saakka. Lisäksi hän on toiminut alalla useissa johtotehtävissä vuodesta 2005 alkaen. Erik Bengtssonista tulee myös Loxam-konsernin johtoryhmän jäsen.Uuden tehtävänsä ohella Bengtsson jatkaa nykyisessä tehtävässään, kunnes hänen seuraajansa on nimitetty.Jukka Havia on nimitetty Ramirent Oyj:n varatoimitusjohtajaksi 1. tammikuuta 2020 alkaen. Hän raportoi Erik...

Continue reading

Hoivatilat Plc: The Board of Directors of Hoivatilat Plc Supplements its Statement on Aureit Holding Oy’s Voluntary Public Cash Tender Offer for the Shares in Hoivatilat Plc due to the Increase in the Offer Consideration

Hoivatilat PlcStock Exchange Release5 December 2019 at 9:20 a.m. EETNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO BELGIUM, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR HONG KONG OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER INFORMATION, PLEASE SEE SECTION “IMPORTANT INFORMATION” BELOW.The Board of Directors of Hoivatilat Plc Supplements its Statement on Aureit Holding Oy’s Voluntary Public Cash Tender Offer for the Shares in Hoivatilat Plc due to the Increase in the Offer ConsiderationHoivatilat Plc (“Hoivatilat”) and Aedifica SA/NV (“Aedifica”) have on 4 November 2019 announced that Aedifica, through a wholly-owned subsidiary, Aureit Holding Oy (the “Offeror”), will make...

Continue reading

Hoivatilat Oyj: Hoivatilat Oyj:n hallitus täydentää tarjousvastikkeen korotuksen johdosta Aureit Holding Oy:n vapaaehtoista julkista käteisostotarjousta Hoivatilat Oyj:n osakkeista koskevaa lausuntoaan

Hoivatilat OyjPörssitiedote5.12.2019 9:20 EETEI JULKISTETTAVAKSI TAI LEVITETTÄVÄKSI, KOKONAAN TAI OSITTAIN, SUORAAN TAI VÄLILLISESTI BELGIASSA, KANADASSA, JAPANISSA, AUSTRALIASSA, ETELÄ-AFRIKASSA TAI HONGKONGISSA TAI MILLÄÄN MUULLA ALUEELLA MISSÄ OSTOTARJOUS OLISI SOVELLETTAVAN LAIN VASTAINEN. KATSO LISÄTIETOJA ALLA KOHDASTA “TÄRKEITÄ TIETOJA”.Hoivatilat Oyj:n hallitus täydentää tarjousvastikkeen korotuksen johdosta Aureit Holding Oy:n vapaaehtoista julkista käteisostotarjousta Hoivatilat Oyj:n osakkeista koskevaa lausuntoaanHoivatilat Oyj (“Hoivatilat”) ja Aedifica SA/NV (”Aedifica”) ovat 4.11.2019 tiedottaneet, että Aedifica tekee kokonaan omistamansa tytäryhtiö Aureit Holding Oy:n (”Tarjouksentekijä”) kautta vapaaehtoisen Hoivatilojen hallituksen suositteleman käteisostotarjouksen kaikista Hoivatilojen liikkeeseen laskemista...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.